Clinical Trials Logo

Filter by:
NCT ID: NCT04549051 Completed - Adhesive Capsulitis Clinical Trials

Percutaneous Interruption of the Coracohumeral Ligament for the Treatment of Frozen Shoulder

CHLTenex
Start date: November 17, 2020
Phase: N/A
Study type: Interventional

Percutaneous Interruption of the Coracohumeral Ligament for the treatment of Frozen Shoulder.

NCT ID: NCT04549038 Completed - Clinical trials for Hematopoietic Stem Cell Transplant

Time Restricted Nutrition in Pediatric Stem Cell Transplant Recipients

Start date: May 19, 2020
Phase: N/A
Study type: Interventional

Circadian cycles, metabolism, and nutrition are intimately linked, and the timing of meals play an important role in synchronizing peripheral circadian rhythms. There are little data describing the influence of nocturnal feeds on sleep, metabolism, and overall health in hospitalized children. To evaluate this association, the investigators will conduct a single-center, randomized, non-blinded controlled trial that will test the impact of nocturnal enteral/parenteral nutrition on patient outcomes.

NCT ID: NCT04548895 Completed - Covid19 Clinical Trials

Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19

Start date: December 30, 2020
Phase:
Study type: Observational

Solving the problem of detecting asymptomatic carriers who can transmit infection is key to protecting vulnerable residents of nursing homes and assisted living facilities, to protecting frontline workers who care for them, and to facilitating return to work (including return of nurses and medical assistants). The wearable biometric technology, if widely disseminated among vulnerable populations and the community-at-large, will help avoid the ravages of seasonal flu and other contagious illnesses, and the society will be better prepared for future waves of COVID-19 or other pandemics. Even if a vaccine is developed, due to immune senescence and immunocompromise, elderly people and those with chronic medical conditions may not be well protected by it. Continuous biomonitoring provides another layer of protection for them.

NCT ID: NCT04548765 Completed - Cancer Colorectal Clinical Trials

Evaluation of Letters Promoting Colorectal Cancer Testing

Start date: July 24, 2020
Phase: N/A
Study type: Interventional

In this evaluation, 4 different versions of letters are being sent with mailers promoting colorectal cancer screening with an at-home test. The researchers hypothesize that the use of behavioral nudges in the message should lead to increased colorectal cancer screening (either with the at-home test or a colonoscopy).

NCT ID: NCT04548635 Completed - Acute Pain Clinical Trials

VR for Burn Dressing Changes at Home

Start date: September 5, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate the impact of our smartphone-based Virtual Reality Pain Alleviation Tool (VR-PAT) during the repeated at-home burn dressing changes of children (5-17 years) with a burn injury in comparison with a control group of children with a burn injury who will not use VR-PAT during at-home burn dressing changes. We hypothesize that children using VR-PAT will report less pain during their dressing changes.

NCT ID: NCT04548544 Completed - Healthy Clinical Trials

A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19

Start date: October 18, 2019
Phase: N/A
Study type: Interventional

The COVID-19 pandemic has been significantly affecting people's lives around the globe. Social distancing, self-quarantine, shelter-in-place measures, economic challenges, and COVID-19-cased illness and deaths have the potential to significantly impact mental health and cause stress, anxiety, and depression. Adolescents may be especially vulnerable to this situation, due to their increased vulnerability to the onset of depression and anxiety in general. One promising approach to reduce anxiety and depression in youth is a neuroscience-based mindfulness intervention Training for Awareness Resilience and Action (TARA) (Henje Blom et al., 2014). TARA is usually delivered over 12 weeks by two facilitators in groups of 10-15 adolescents in-person, and it has been shown to reduce symptoms of depression and anxiety in depressed adolescents (Henje Blom et al., 2016) and modify brain properties (Yuan et al., 2020). The TARA intervention can also be delivered remotely. Other types of therapy delivered remotely, such as internet-based cognitive behavioral therapy, have shown comparable efficiency to face-to-face delivery (Carlbring et al., 2017). The objective of this study is to utilize an individually randomized group treatment, open-label, waitlist-controlled clinical trial to test the feasibility of TARA (delivered partially over Zoom) in improving the self-reported emotional well-being primary outcome (emotional problems measured with the Strengths and Difficulties Questionnaire [SDQ]) in healthy adolescents between the ages of 14 to 18 years old during the COVID-19 pandemic. Our central hypothesis is that emotional well-being of adolescents in the intervention group will improve stronger (or deteriorate less) than in the control group. We will test this hypothesis in 21 adolescents randomized to the TARA intervention (partially delivered over Zoom) (12 adolescents) or to the waitlist control group (9 adolescents).

NCT ID: NCT04548531 Completed - Colon Cancer Clinical Trials

Engaging Patients in Colon Cancer Screening Decisions During COVID-19

Start date: September 10, 2020
Phase: N/A
Study type: Interventional

The goal of the study is to examine whether a shared decision making intervention improves decision making about colon cancer screening for patients who had their colonoscopy delayed or postponed due to the COVID pandemic. Eligible patients (n=800) will be randomly assigned to either the intervention or control arm. A subset will be surveyed about 6-8 weeks post intervention to measure shared decision making, their intention to follow through with screening, and their decisional conflict. Study staff will conduct medical chart review to track receipt of colon cancer screening within 6 months. The statistician will test whether patients in the intervention arm report more shared decision making, less decisional conflict, higher intention to follow through on screening and have higher screening rates compared to those in the control arm.

NCT ID: NCT04548349 Completed - Healthy Clinical Trials

Profiling the Skin Microbiome in Response to Altreno in Acne Patients

Start date: April 23, 2021
Phase: Phase 4
Study type: Interventional

The study objective is to characterize the shift in the diversity and abundance of the skin microbial community at baseline and in response to Altreno monotherapy as compared to benzoyl peroxide (BPO) 2.5% leave-on gel monotherapy in acne patients.

NCT ID: NCT04548219 Completed - Healthy Clinical Trials

A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants

Start date: September 11, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare two different formulations of mirikizumab in healthy participants. This study will compare how much of each formulation gets into the blood stream and how long it takes the body to remove it. Information about any side effects that may occur will also be collected. Participants will remain in the study for about 12 weeks, after receiving study drug.

NCT ID: NCT04548193 Completed - Clinical trials for Stage 0is Bladder Cancer AJCC v8

Behavioral Dietary Intervention for the Improvement of Bladder Cancer Survivorship

Start date: April 5, 2021
Phase: Phase 1
Study type: Interventional

This phase I trial investigates how well a healthy eating program works in improving outcomes in patients with bladder cancer. The behavioral dietary program consists of educational materials, live phone calls, and interactive voice response phone messages. Participating in the healthy eating program may improve eating habits and/or reduce the risk of bladder cancer from coming back.